Free Trial
NASDAQ:BCAX

Bicara Therapeutics (BCAX) Stock Price, News & Analysis

Bicara Therapeutics logo
$10.67 -0.44 (-3.97%)
As of 03:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Bicara Therapeutics Stock (NASDAQ:BCAX)

Key Stats

Today's Range
$10.64
$11.17
50-Day Range
$8.71
$15.66
52-Week Range
$7.80
$28.09
Volume
197,175 shs
Average Volume
625,578 shs
Market Capitalization
$581.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.86
Consensus Rating
Buy

Company Overview

Receive BCAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCAX Stock News Headlines

Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.
BCAX Bicara Therapeutics Inc.
See More Headlines

BCAX Stock Analysis - Frequently Asked Questions

Bicara Therapeutics' stock was trading at $17.42 at the start of the year. Since then, BCAX stock has decreased by 38.8% and is now trading at $10.6690.

Bicara Therapeutics Inc. (NASDAQ:BCAX) issued its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.40) by $0.28.

Bicara Therapeutics (BCAX) raised $315 million in an initial public offering (IPO) on Friday, September 13th 2024. The company issued 17,500,000 shares at $18.00 per share.

Top institutional investors of Bicara Therapeutics include TD Asset Management Inc (0.41%) and Atle Fund Management AB (0.27%).
View institutional ownership trends
.

Shares of BCAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/13/2025
Today
8/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCAX
Previous Symbol
NASDAQ:BCAX
CIK
2023658
Fax
N/A
Employees
32
Year Founded
N/A

Price Target and Rating

High Price Target
$48.00
Low Price Target
$8.00
Potential Upside/Downside
+186.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
24.62
Quick Ratio
24.62

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.04 per share
Price / Book
1.23

Miscellaneous

Outstanding Shares
54,536,000
Free Float
46,083,000
Market Cap
$605.89 million
Optionable
N/A
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BCAX) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners